Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial

H. Iwata; N. Masuda; Y. Yamamoto; T. Fujisawa; T. Toyama; N. Taira; M. Kashiwaba; S. Ohtani; T. Sakai; Y. Hasegawa; R. Nakamura; H. Akabane; Y. Shibahara; H. Sasano; T. Yamaguchi; Y. Ohashi

doi:10.1093/annonc/mdy270.182

Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial

H. Iwata, N. Masuda, Y. Yamamoto, T. Fujisawa, T. Toyama, N. Taira, M. Kashiwaba, S. Ohtani, T. Sakai, Y. Hasegawa, R. Nakamura, H. Akabane, Y. Shibahara, H. Sasano, T. Yamaguchi, Y. Ohashi

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii58
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy270.182
Publication status	Published - 2018 Oct 1

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy270.182

Cite this

Iwata, H., Masuda, N., Yamamoto, Y., Fujisawa, T., Toyama, T., Taira, N., Kashiwaba, M., Ohtani, S., Sakai, T., Hasegawa, Y., Nakamura, R., Akabane, H., Shibahara, Y., Sasano, H., Yamaguchi, T., & Ohashi, Y. (2018). Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii58. https://doi.org/10.1093/annonc/mdy270.182

Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET) : 6-year analysis in phase III NEOS trial. / Iwata, H.; Masuda, N.; Yamamoto, Y. et al.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii58.

Research output: Contribution to journal › Article › peer-review

Iwata, H, Masuda, N, Yamamoto, Y, Fujisawa, T, Toyama, T, Taira, N, Kashiwaba, M, Ohtani, S, Sakai, T, Hasegawa, Y, Nakamura, R, Akabane, H, Shibahara, Y, Sasano, H, Yamaguchi, T & Ohashi, Y 2018, 'Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii58. https://doi.org/10.1093/annonc/mdy270.182

@article{1c03d2977a8941fdbb74d7b1e0d171aa,

title = "Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial",

author = "H. Iwata and N. Masuda and Y. Yamamoto and T. Fujisawa and T. Toyama and N. Taira and M. Kashiwaba and S. Ohtani and T. Sakai and Y. Hasegawa and R. Nakamura and H. Akabane and Y. Shibahara and H. Sasano and T. Yamaguchi and Y. Ohashi",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy270.182",

language = "English",

volume = "29",

pages = "viii58",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET)

T2 - 6-year analysis in phase III NEOS trial

AU - Iwata, H.

AU - Masuda, N.

AU - Yamamoto, Y.

AU - Fujisawa, T.

AU - Toyama, T.

AU - Taira, N.

AU - Kashiwaba, M.

AU - Ohtani, S.

AU - Sakai, T.

AU - Hasegawa, Y.

AU - Nakamura, R.

AU - Akabane, H.

AU - Shibahara, Y.

AU - Sasano, H.

AU - Yamaguchi, T.

AU - Ohashi, Y.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081532683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081532683&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy270.182

DO - 10.1093/annonc/mdy270.182

M3 - Article

C2 - 32137533

SN - 0923-7534

VL - 29

SP - viii58

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this